|
To learn more about Sanofi's Sarclisa, click here.
With many chemo and ADHD drugs stuck in stubborn shortages, several agencies are looking for new solutions to boost supplies.Details >In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.Details >
• Astellas XTANDI Support Solutions
• Boehringer Ingelheim Cares Foundation
• Deciphera Access Point Details >
No new, retired, and revised policies/articlesDetails >• J0881 and J0885 Coverage & Billing Requirements
• Providers Inappropriately Deactivated
• Targeted Probe & Educate Problem Error Rates
• Updated Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• New CMS Guidance
• Part B Drug Payment Limits Overview
• HHS Final Rule Clarifying the Eligibility of DACA
• MLN Matters
• And More Details >This edition includes articles on• Discharge Appeals to be Rerouted by Kepro
• Malice or Stupidity
• Coverage Expanded to DACA Recipients
• Efficient, Effective Patient Access Operations Details >
Recent Oncology Related News• BCBSM Carelon Authorization Letter Revised! Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 5-14-24• New! 0885 Claims Denied
• New! Procrit Denials (693)
• Procrit or Epoetin Class Drugs Maintenance
• And More Details >Last Reviewed/Updated 5-14-24• BCBSM Carelon Letter
• BCBSM Reimbursement on MVASI Details >• Site of Care for Specialty Drugs
• Submitting Precertification Request
• April Newsletter Details >• Two Midnight Rule Clarification
• Keep Provider Information Updated in NPPES
• Prior Auth & Benefit Coverage Policy Updates Details >• Beneficiary Co-Payment Requirements
• MMP Bulletins
• Biller "B" Aware Notices Details >• Evolent Oncology Prior Auth Changes
• FAQ: Evolent Quality Management Program
• Clinical & Payment Policies
• Change Healthcare Connection FAQ Details >• Medicaid Claims Being Rejected Incorrectly
• Formulary Changes Coming July 1
• PriceMyMeds Launched on April 25
• Provider Enrolled in Multiple ACN Contracts
• And More Details >• Reimbursement Policy Updates
• Medical Policy Updates
• Medical Benefit Drug Policy Updates Details >
• Genentech Alecensa
• Johnson & Johnson Carvykti
• SeaGen & Genmab Tivdak
Details > • Explore Updated Results From AstraZeneca's TOPAZ-1 Study Details >
May 2024 Frequently Asked Questions• EFT for CHAMPVA
• Billing Incident-To Services
• How Does NCCI Impact Coding?
• Code 88342 Details > |
